Tag: Center for Biologics Evaluation and Research

Marty Makary and Vinay Prasad embrace a “more fluid concept of evidence” at the FDA

Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "more fluid concept of evidence" now reigns at the FDA—selectively.